ArticleOncoimmunology2022

A newly discovered PD-L1 B-cell epitope peptide vaccine (PDL1-Vaxx) exhibits potent immune responses and effective anti-tumor immunity in multiple syngeneic mice models and (synergizes) in combination with a dual HER-2 B-cell vaccine (B-Vaxx).

Linlin Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.